Concepedia

Sravya Kommineni

SK

Statistics

Publications

11

Citations

2.1K

H-Index

11

Active since

2011

Affiliations

Novartis (United States)(Current)

Novartis (Switzerland)

Broad Institute

Harvard University

Harvard Stem Cell Institute

Sravya Kommineni is an author at Novartis (United States) specializing in life sciences, molecular biology, and crispr-cas9 genome editing.

Publications per year

2011–2023

11

Publications

11

p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells

Robert J. Ihry, Kathleen A. Worringer, Max R. Salick et al. · Nature Medicine · 2018 · 1K citations

, , +12

Combining NGN2 Programming with Developmental Patterning Generates Human Excitatory Neurons with NMDAR-Mediated Synaptic Transmission

Ralda Nehme, Emanuela Zuccaro, Sulagna Ghosh et al. · Cell Reports · 2018 · 276 citations · Full text

, , +17

Genetic Ablation of AXL Does Not Protect Human Neural Progenitor Cells and Cerebral Organoids from Zika Virus Infection

Michael F. Wells, Max R. Salick, Ole Wiskow et al. · Cell stem cell · 2016 · 265 citations · Full text

, , +17

ADAM17 is the main sheddase for the generation of human triggering receptor expressed in myeloid cells (hTREM2) ectodomain and cleaves TREM2 after Histidine 157

Dominik Feuerbach, Patrick Schindler, Carmen Barske et al. · Neuroscience Letters · 2017 · 186 citations

, , +4

GABARAP sequesters the FLCN-FNIP tumor suppressor complex to couple autophagy with lysosomal biogenesis

Jonathan M. Goodwin, Ward G. Walkup, Kirsty M. Hooper et al. · Science Advances · 2021 · 126 citations · Full text

, , +14

1–5 of 11